06 MAR 2016 by ideonexus
Fever-Reducer Extends Illness
Multivariate analysis suggested that antipyretic therapy prolonged illness in subjects infected with influenza A, but its use was the result of prolonged illness in those infected with S. sonnei. The precise nature of these relationships requires a prospective, randomized, placebo-controlled trial.
1 
This was an unintended discovery of the research on different types of influenza. Subjects who took fever-reducer were ill 3.5 days longer than those who did not.
